TITLE

Sirtuin 1 (SIRT1) Activation Mediates Sildenafil Induced Delayed Cardioprotection against Ischemia-Reperfusion Injury in Mice

AUTHOR(S)
Shalwala, Mona; Zhu, Shu-Guang; Das, Anindita; Salloum, Fadi N.; Xi, Lei; Kukreja, Rakesh C.
PUB. DATE
January 2014
SOURCE
PLoS ONE;Jan2014, Vol. 9 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: It has been well documented that phosphodiesterase-5 inhibitor, sildenafil (SIL) protects against myocardial ischemia/reperfusion (I-R) injury. SIRT1 is part of the class III Sirtuin family of histone deacetylases that deacetylates proteins involved in cellular stress response including those related to I-R injury. Objective/Hypothesis: We tested the hypothesis that SIL-induced cardioprotection may be mediated through activation of SIRT1. Methods: Adult male ICR mice were treated with SIL (0.7 mg/kg, i.p.), Resveratrol (RSV, 5 mg/kg, a putative activator of SIRT1 used as the positive control), or saline (0.2 mL). The hearts were harvested 24 hours later and homogenized for SIRT1 activity analysis. Results: Both SIL- and RSV-treated mice had increased cardiac SIRT1 activity (P<0.001) as compared to the saline-treated controls 24 hours after drug treatment. In isolated ventricular cardiomyocytes, pretreatment with SIL (1 µM) or RSV (1 µM) for one hour in vitro also upregulated SIRT1 activity (P<0.05). We further examined the causative relationship between SIRT1 activation and SIL-induced late cardioprotection. Pretreatment with SIL (or RSV) 24 hours prior to 30 min ischemia and 24 hours of reperfusion significantly reduced infarct size, which was associated with a significant increase in SIRT1 activity (P<0.05). Moreover, sirtinol (a SIRT1 inhibitor, 5 mg/kg, i.p.) given 30 min before I-R blunted the infarct-limiting effect of SIL and RSV (P<0.001). Conclusion: Our study shows that activation of SIRT1 following SIL treatment plays an essential role in mediating the SIL-induced cardioprotection against I-R injury. This newly identified SIRT1-activating property of SIL may have enormous therapeutic implications.
ACCESSION #
94235854

 

Related Articles

  • Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction. Thummasorn, Savitree; Apaijai, Nattayaporn; Kerdphoo, Sasiwan; Shinlapawittayatorn, Krekwit; Chattipakorn, Siriporn C.; Chattipakorn, Nipon // Cardiovascular Therapeutics;Dec2016, Vol. 34 Issue 6, p404 

    Aim Myocardial reperfusion via the re-canalization of occluded coronary arteries is gold standard for the treatment of acute myocardial infarction. However, reperfusion itself can cause myocardial damage due to increased reactive oxygen species ( ROS) production, a process known as...

  • Administration of minocycline ameliorates damage in a renal ischemia/reperfusion injury model. Dan Xia; Kezhen Shen; Weide Zhong; Hao Pan // Clinical & Investigative Medicine;Apr2011, Vol. 34 Issue 2, pE55 

    Purpose: The purpose of this study was to investigate the effects of minocycline on the renal dysfunction and injury caused by bilateral ischemia/reperfusion (I/R) of murine kidneys in vito. Methods: Male C57BL/6 mice were administered minocycline (45 mg/kg i.v.) or saline (0.9%, v/v, NaCl) 36...

  • A Mechanism Study Underlying the Protective Effects of Cyclosporine-A on Lung Ischemia-Reperfusion Injury. Li, Jian''an; Yan, Zhongya; Fang, Qianjin // Pharmacology;May2017, Vol. 100 Issue 1/2, p83 

    Aim: This study is aimed at validating the hypothesis that administration of cyclosporine-A (CsA) would be protective in lung ischemia-reperfusion (I/R) injury and in exploring the underlying mechanism. Methods: Rabbits were divided into 4 groups: the control, sham operation, I/R, and I/R with...

  • There is More to Life than Revascularization: Therapeutic Targeting of Myocardial Ischemia/Reperfusion Injury. Bell, Robert M.; Yellon, Derek M. // Cardiovascular Therapeutics;Dec2011, Vol. 29 Issue 6, pe67 

    Ischemic heart disease is the world's leading cause of death, and while clinical advances have meant improved and more rapid revascularization, there remains a significant element of myocardial death that thus far has not been successfully targeted in clinical practice, namely lethal reperfusion...

  • Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules. Nagata, Takanobu; Yasukawa, Hideo; Kyogoku, Sachiko; Oba, Toyoharu; Takahashi, Jinya; Nohara, Shoichiro; Minami, Tomoko; Mawatari, Kazutoshi; Sugi, Yusuke; Shimozono, Koutatsu; Pradervand, Sylvain; Hoshijima, Masahiko; Aoki, Hiroki; Fukumoto, Yoshihiro; Imaizumi, Tsutomu // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Myocardial ischemia reperfusion injury (IRI) adversely affects cardiac performance and the prognosis of patients with acute myocardial infarction. Although myocardial signal transducer and activator of transcription (STAT) 3 is potently cardioprotective during IRI, the inhibitory mechanism...

  • Superagonistic CD28 Protects against Renal Ischemic Injury by Expansion of Regulatory T-Cell. Liang, Yiran; Li, Yan; Kuang, Qing; Ding, Xiaoqiang; Wei, Zheng; Fang, Yi // American Journal of Nephrology;May2017, Vol. 45 Issue 5, p389 

    Background: Regulatory T (Treg) cells are a highly suppressive subset of CD4+ lymphocytes and have recently been proved to be crucial to suppress the inflammatory responses of ischemic kidney injury. CD28 superagonists (CD28sa) are monoclonal antibodies that preferentially expand...

  • Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Meng-Yu Wu; Giou-Teng Yiang; Wan-Ting Liao; Andy Po-Yi Tsai; Yeung-Leung Cheng; Pei-Wen Cheng; Chia-Ying Li; Chia-Jung Li // Cellular Physiology & Biochemistry (Karger AG);May2018, Vol. 46 Issue 4, p1650 

    Ischemia-reperfusion injury is associated with serious clinical manifestations, including myocardial hibernation, acute heart failure, cerebral dysfunction, gastrointestinal dysfunction, systemic inflammatory response syndrome, and multiple organ dysfunction syndrome. Ischemia-reperfusion injury...

  • Cardioprotective Effects of MET-88, a Gamma-Butyrobetaine Hydroxylase Inhibitor, on Cardiac Dysfunction Induced by Ischemia/Reperfusion in Isolated Rat Hearts. Hayashi, Yukio; Tajima, Kiyotaka; Kirimoto, Tsukasa; Miyake, Hidekazu; Matsuura, Naosuke // Pharmacology;Nov2000, Vol. 61 Issue 4, p238 

    Inhibition of fatty acid metabolite accumulation may be beneficial for treatment of cardiac dysfunction induced by ischemia. MET-88, 3-(2,2,2-trimethylhydrazinium)propionate dihydrate, inhibits γ-butyrobetaine hydroxylase which catalyzes conversion of γ-butyrobetaine to carnitine. In this...

  • Protective Effect of Platelet Rich Plasma on Experimental Ischemia/Reperfusion Injury in Rat Ovary. Bakacak, Murat; Bostanci, Mehmet Suhha; İnanc, Fatma; Yaylali, asli; Serin, Salih; attar, Rukset; Yildirim, Gazi; Yildirim, Ozge Kizilkale // Gynecologic & Obstetric Investigation;May2016, Vol. 81 Issue 3, p225 

    Background/aims: Ovarian torsion is a common cause of local ischemic damage, reduced follicular activity and infertility. Platelet-rich plasma (PRP) contains growth factors with demonstrated cytoprotective properties; so we evaluated PRP efficacy in a rat ischemia/reperfusion (I/R)...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics